Kaposi varicelliform eruption associated with 0.1% tacrolimus ointment treatment in atopic blepharitis.
OBJECTIVE
To report the association of Kaposi varicelliform eruption (KVE) with 0.1% tacrolimus ointment treatment of atopic blepharitis in a patient with atopic dermatitis (AD).


METHODS
We encountered KVE in a 20-year-old male patient with atopic blepharitis and AD who developed generalized herpetic lesions on his face 28 days after commencement of treatment.


RESULTS
The lesions resolved quickly with intravenous acyclovir treatment.


CONCLUSIONS
Ophthalmologists should be well aware of KVE as a complication of immunosuppressive treatment in patients with atopic blepharitis.
Miyake-Kashima
Minori
M
Department of Ophthalmology, Tokyo Dental College, Chiba 272-8513, Japan. minori.miyake@nifty.ne.jp
Fukagawa
Kazumi
K
Tanaka
Mari
M
Takano
Yoji
Y
Dogru
Murat
M
Asano-Kato
Naoko
N
Takahashi
Shin-Ichi
S
Fujishima
Hiroshi
H
D000212:Acyclovir / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D001762:Blepharitis / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007617:Kaposi Varicelliform Eruption / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D009824:Ointments; D016559:Tacrolimus / Q000009:adverse effects*; D014775:Virus Activation / Q000187:drug effects
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D009824:Ointments; D016559:Tacrolimus; D000212:Acyclovir